[RuCl3ind3] and [RuCl2ind4]: Two new ruthenium complexes derived from the tumor-inhibiting RuIII compound HInd (OC-6-11)-[RuCl4ind2] (ind = indazole)

Zeitschrift fur Anorganische und Allgemeine Chemie

Volumn 627, Issue 2, 2001, Pages 261-265

  Pieper, Thomas ^a   Sommer, Martina ^a   Galanski, Markus ^a   Keppler, Bernhard K ^a   Giester, Gerald ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antitumor agents; Coordination chemistry; Paramagnetic complexes; Ruthenium

Indexed keywords

EID: 21244504647     PISSN: 00442313     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-3749(200102)627:2<261::aid-zaac261>3.0.co;2-k     Document Type: Article

References (25)

1. M. J. Clarke, Metal Complexes in Cancer Chemotherapy; B. K. Keppler (ed), VCH Weinheim, 1993, 129.
2. E. Alessio, A. Balducci, A. Lutman, G. Mestroni, M. Calligaris, W. M. Attia, Inorg. Chim. Acta 1993, 203, 205.
3. R. Vilaplana, M. A. Romero, M. Quiros, J. M. Salas, F. Gonzalez-Vilchez, Metal Based Drugs 1995, 2, 211.
4. P. M. van Vliet, S. M. S. Toekimin, J. G. Haasnoot, J. Reedijk, O. Novakova, O. Vrana, V. Brabec, Inorg. Chim. Acta 1995, 231, 57.
5. G. Mestroni, E. Alessio, S. Sava, S. Pacor, M. Coluccia, A. Boccarelli, Metal Based Drugs 1993, 1, 41.
6. E. Alessio, G. Mestroni, G. Sava, A. Bergamo, M. Coluccia, L. Messori, Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment, N. D. Hadjiliadis (ed), Kluwer Academic Publishers, Netherlands, 1997, 457.
7. S. Sava, I. Capozzi, K. Clerici, G. Gagliardi, E. Alessio, G. Mestroni, Clin. Exp. Metastasis 1998, 16, 371.
8. B. K. Keppler, K. G. Lipponer, B. Stenzel, F. Kratz, Metal Complexes in Cancer Chemotherapy; B. K. Keppler (ed), VCH Weinheim, 1993, 187.
9. M. Seelig, M. R. Berger, B. K. Keppler, D. Schmähl, Metal Ions in Biology and Medicine; Ph. Collery, L. A. Poirier, M. Manfait, J. C. Etienne (eds), John Libbey Eurotext: Paris, 1990, 476.
10. A. Galeano, M. R. Berger, B. K. Keppler, Arzneimittelforschung/Drug Research 1992, 42(1), 6, 821.
11. H. Depenbrock, S. Schmelcher, R. Peter, B. K. Keppler, G. Weirich, T. Block, J. Rastetter, A. R. Hanauske, Europ. J. Cancer 1997, 33, 2404.
12. F. Kratz, M. Hartmann, B. K. Keppler, L. Messori, J. Biol. Chem. 1996, 269, 2581.
13. C. A. Smith, A. J. Sutherland-Smith, B. K. Keppler, F. Kratz, E. N. Baker, J. Bioinorg. Chem. 1996, 1, 424.
14. M. J. Clarke, S. Bitler, D. Rennert, M. Buchbinder, A. D. Kelman, J. Inorg. Biochem. 1980, 12, 79.
15. D. Frasca, J. Ciampa, J. Emerson, R. S. Umans, M. J. Clarke, Metal-Based Drugs 1996, 3, 197.
16. J. Chatlas, R. van Eldik, B. K. Keppler, Inorg. Chim. Acta 1995, 253, 59.
17. O. M. Ni Dhubhgaill, W. R. Hagen, B. K. Keppler, K. G. Lipponer, P. Sadler, J. Chem. Soc., Dalton Trans. 1994, 3305.
18. C. Anderson, A. L. Beauchamp, Can. J. Chem. 1995, 73, 471.
19. T. Pieper, M. Hartmann, M. Sommer, B. K. Keppler, J. Cancer Res. Clin. Oncol. 1997, 123, S35.
20. T. Pieper, W. Peti, B. K. Keppler, Metal-Based Drugs 2000, in press.
21. W. Peti, T. Pieper, M. Sommer, B. K. Keppler, G. Giester, Eur. J. Inorg. Chem. 1999, 1551.
22. W.-T. Wong, T.-C. Lau, Acta Crystallogr. 1994, C50, 1406.
23. K. G. Lipponer, E. Vogel, B. K. Keppler, Metal-Based Drugs 1996, 3, 243.
24. G. M. Sheldrick, SHELXS-97, A Program for the Solution of Crystal Structures, University of Göttingen, Germany, 1997.
25. G. M. Sheldrick, SHELXL-97, A Program for Crystal Structure Refinement, University of Göttingen, Germany, 1997.